Government Pushes Generic Medicines, Mandates Doctor Prescriptions
Quick Revision
The government is intensifying efforts to promote generic medicines.
Generic drugs should only be dispensed based on a doctor's prescription.
The initiative aims to enhance affordability and accessibility of healthcare.
Concerns about the quality and efficacy of generic drugs are being addressed.
The policy mandates strict quality control for generic medicines.
Awareness is needed among both medical professionals and the public regarding generic drugs.
This policy is crucial for achieving universal healthcare.
Visual Insights
जेनेरिक दवाओं और PMBJP का प्रभाव (मार्च 2026 तक)
यह डैशबोर्ड भारत में जेनेरिक दवाओं को बढ़ावा देने और प्रधानमंत्री भारतीय जनऔषधि परियोजना (PMBJP) के प्रमुख प्रभावों को दर्शाता है, जिसमें नागरिकों की बचत, जनऔषधि केंद्रों का विस्तार और स्वास्थ्य पर जेब से होने वाले खर्च में कमी शामिल है।
- PMBJP द्वारा कुल बचत (पिछले दशक में)
- ₹30,000 करोड़
- जनऔषधि केंद्रों की संख्या (जून 2025 तक)
- 16,912+3,088 (मार्च 2026 तक लक्ष्य)
- स्वास्थ्य पर जेब से होने वाला खर्च (OOP) में कमी
- 39.4%62.6% से घटकर (2014-15)
यह आंकड़ा दर्शाता है कि कैसे PMBJP ने लाखों परिवारों को महंगी ब्रांडेड दवाओं के बोझ से बचाया है, जिससे स्वास्थ्य सेवा अधिक किफायती हुई है।
देश भर में जनऔषधि केंद्रों का तेजी से विस्तार जेनेरिक दवाओं की पहुंच और उपलब्धता बढ़ाने में सरकार की प्रतिबद्धता को दर्शाता है, खासकर ग्रामीण और दूरदराज के इलाकों में।
OOP खर्च में यह महत्वपूर्ण कमी सार्वभौमिक स्वास्थ्य कवरेज की दिशा में भारत की प्रगति को दर्शाती है, जिससे स्वास्थ्य सेवाओं के कारण होने वाली वित्तीय कठिनाइयाँ कम होती हैं।
जेनेरिक दवाओं और प्रिस्क्रिप्शन नीतियों का विकास
यह टाइमलाइन भारत में जेनेरिक दवाओं को बढ़ावा देने और डॉक्टरों द्वारा प्रिस्क्रिप्शन लिखने के नियमों से संबंधित प्रमुख ऐतिहासिक और हालिया घटनाओं को दर्शाती है।
भारत में सस्ती और सुलभ स्वास्थ्य सेवा सुनिश्चित करने के लिए जेनेरिक दवाओं को बढ़ावा देने और प्रिस्क्रिप्शन प्रथाओं को विनियमित करने का एक लंबा इतिहास रहा है। MCI विनियमों से लेकर PMBJP के पुनर्गठन और हालिया नियामक निर्देशों तक, सरकार लगातार इस दिशा में काम कर रही है ताकि नागरिकों पर स्वास्थ्य खर्च का बोझ कम हो और दवा सुरक्षा सुनिश्चित हो।
- 2002भारतीय चिकित्सा परिषद (MCI) विनियम, 2002: डॉक्टरों को जेनेरिक नाम से दवाएं लिखने के लिए प्रोत्साहित किया गया।
- 2008जनऔषधि अभियान शुरू: सस्ती जेनेरिक दवाओं की उपलब्धता बढ़ाने का प्रारंभिक प्रयास।
- 2015प्रधानमंत्री भारतीय जनऔषधि परियोजना (PMBJP) का पुनर्गठन: जनऔषधि अभियान को मजबूत किया गया।
- 2018आयुष्मान भारत योजना का शुभारंभ: सार्वभौमिक स्वास्थ्य कवरेज की दिशा में एक बड़ा कदम।
- 2020भारतीय चिकित्सा परिषद (MCI) को राष्ट्रीय चिकित्सा आयोग (NMC) द्वारा प्रतिस्थापित किया गया।
- 2021-22स्वास्थ्य पर जेब से होने वाला खर्च (OOP) घटकर 39.4% हुआ (2014-15 में 62.6% से)।
- FY24PMBJP ने ₹1,470 करोड़ की बिक्री दर्ज की, जिससे नागरिकों को ₹7,350 करोड़ की बचत हुई।
- जून 2025PMBJP के तहत 16,912 जनऔषधि केंद्र खोले गए।
- नवंबर 2025पंजाब और हरियाणा हाई कोर्ट ने स्पष्ट प्रिस्क्रिप्शन को मरीजों का 'मौलिक अधिकार' बताया।
- दिसंबर 2025राष्ट्रीय चिकित्सा आयोग (NMC) ने मेडिकल कॉलेजों को प्रिस्क्रिप्शन प्रथाओं की निगरानी के लिए उप-समितियां बनाने का निर्देश दिया।
- फरवरी 2026महाराष्ट्र के चिकित्सा शिक्षा और अनुसंधान निदेशालय (DMER) ने प्रिस्क्रिप्शन निगरानी के लिए उप-समितियां स्थापित करने का निर्देश दिया।
- मार्च 2026केंद्रीय औषधि मानक नियंत्रण संगठन (CDSCO) ने वजन घटाने वाली दवा सेमाग्लूटाइड के जेनेरिक संस्करणों की बिक्री केवल डॉक्टर के प्रिस्क्रिप्शन पर करने की सलाह जारी की।
- मार्च 2026सरकार का PMBJP के तहत जनऔषधि केंद्रों की संख्या 20,000 तक बढ़ाने का लक्ष्य।
Mains & Interview Focus
Don't miss it!
The government's renewed emphasis on promoting generic medicines, coupled with the mandate for doctor prescriptions, represents a critical policy intervention in India's healthcare landscape. This move directly addresses the exorbitant out-of-pocket expenditure on medicines, a significant barrier to universal health coverage. For too long, branded drugs, often chemically identical to their generic counterparts, have inflated healthcare costs, pushing millions into poverty annually.
This policy aligns with the broader objectives of the National Health Policy 2017, which advocates for affordable healthcare access. The directive for doctors to prescribe generic names, rather than specific brands, is crucial. Without this, the pharmaceutical lobby's influence on prescription patterns, often through unethical incentives, undermines the very purpose of generic drug promotion. The Medical Council of India (Professional Conduct, Etiquette and Ethics) Regulations, 2002, already stipulate that physicians should prescribe drugs by their generic names, yet enforcement has been lax.
However, the success of this initiative hinges on robust regulatory oversight. Concerns about the quality and efficacy of generic drugs, though often unfounded for approved products, persist among both medical professionals and the public. The Central Drugs Standard Control Organisation (CDSCO) must intensify its surveillance and testing mechanisms to build trust. A transparent, real-time quality assurance framework, perhaps akin to the US FDA's stringent approval process, is indispensable.
Furthermore, a sustained public awareness campaign is essential. Citizens must understand that generic drugs are not 'inferior' but merely cost-effective alternatives. Simultaneously, medical colleges and professional bodies must actively educate doctors on the ethical imperative and economic benefits of prescribing generics. This dual approach, combining regulatory enforcement with public and professional education, will be key to transforming India's pharmaceutical market.
Ultimately, this policy is a step towards realizing the implicit Right to Health under Article 21 of the Constitution. It will only achieve its full potential if accompanied by structural reforms in drug procurement, distribution, and pricing, ensuring that the benefits of affordability reach the last mile. The government must also consider strengthening public sector drug manufacturing and distribution networks to counter market distortions.
Exam Angles
GS Paper II: Social Justice - Issues relating to development and management of Social Sector/Services relating to Health.
GS Paper II: Governance - Government policies and interventions for development in various sectors.
GS Paper III: Economy - Issues relating to planning, mobilization of resources, growth, development and employment. Science and Technology - Developments and their applications and effects in everyday life.
View Detailed Summary
Summary
The government wants to make healthcare cheaper by encouraging the use of generic medicines, which are affordable versions of branded drugs. To ensure these medicines are safe and effective, doctors must specifically prescribe them, and the government is also focusing on strict quality checks.
The Government of India has intensified its efforts to promote generic medicines across the nation, aiming to significantly enhance healthcare affordability and accessibility for all citizens. A key aspect of this renewed push is the explicit reiteration that generic drugs must only be dispensed based on a doctor's prescription. This directive addresses long-standing concerns regarding the quality and efficacy of generic medicines, ensuring that their use is medically guided and safe.
The initiative is strategically designed to reduce the overall healthcare costs borne by citizens, thereby making essential medicines more affordable. However, the policy also underscores the critical need for robust quality control mechanisms and widespread awareness campaigns. These campaigns target both medical professionals, to encourage the prescription of generics, and the general public, to build trust and understanding regarding their benefits and safety.
This policy is a crucial step towards achieving universal health coverage in India, ensuring that economic barriers do not prevent access to necessary medical treatment. It is highly relevant for the UPSC Civil Services Exam, particularly under General Studies Paper II (Social Justice, Health) and General Studies Paper III (Economy, Science and Technology).
Background
Latest Developments
Frequently Asked Questions
1. Why is the government reiterating the push for generic medicines and mandatory prescriptions now, even though this has been an ongoing effort?
The renewed emphasis stems from the persistent challenge of high healthcare costs in India, which continues to burden citizens. Despite previous initiatives like PMBJP, the full potential of generic medicines in enhancing affordability and accessibility hasn't been realized. This current push is a stronger directive to ensure wider adoption, explicitly address lingering concerns about quality, and enforce medically guided use through mandatory prescriptions, thereby aiming for a more significant impact on public health expenditure.
2. What specific legal/regulatory frameworks support the government's push for generic medicines and mandate doctors to prescribe by generic names?
The government's push is primarily supported by two key frameworks. The Drugs & Cosmetics Act, 1940, along with its rules, governs the quality, manufacturing, and sale of all drugs, including generics, ensuring their efficacy and safety. Additionally, the Indian Medical Council (Professional Conduct, Etiquette and Ethics) Regulations, 2002, specifically advises registered medical practitioners to prescribe drugs by their generic names. This regulation provides the ethical and professional backing for the mandatory prescription directive.
Exam Tip
UPSC often tests the specific acts and regulations. Remember "Drugs & Cosmetics Act, 1940" for quality control and "Indian Medical Council Regulations, 2002" for doctor's prescription guidelines. Don't confuse the two or their primary focus.
3. Students often confuse generic and branded medicines regarding quality and efficacy. Despite the government's push, is there a real difference that justifies this confusion?
Legally and scientifically, a generic medicine is required to be bioequivalent to its branded counterpart. This means it must contain the same active pharmaceutical ingredient, be identical in dosage form, strength, route of administration, quality, performance characteristics, and intended use. The primary difference lies in the cost, as branded drugs incur significant R&D and marketing expenses that generics do not. The government's push specifically addresses quality concerns by mandating robust quality control mechanisms, aiming to build trust and dispel the misconception that generics are inferior.
4. How will this renewed push for generic medicines impact healthcare affordability and accessibility in India, and what challenges might arise during its implementation?
This renewed push is expected to significantly enhance healthcare affordability by reducing drug costs, making essential medicines accessible to a wider population. It will ease the financial burden on citizens, especially those in lower-income groups. However, implementation faces challenges such as ensuring strict quality control across all generic manufacturers, overcoming resistance from pharmaceutical companies that prioritize branded drugs, changing prescribing habits of doctors, and educating both patients and pharmacists about the efficacy and safety of generics.
5. What is the significance of the Pradhan Mantri Bhartiya JanAushadhi Pariyojana (PMBJP) in the context of the government's strategy to promote generic medicines?
The Pradhan Mantri Bhartiya JanAushadhi Pariyojana (PMBJP) is a flagship initiative launched in 2008 and revamped in 2015, serving as a cornerstone of the government's strategy.
- •It aims to provide quality generic medicines at affordable prices to all.
- •It operates through dedicated 'JanAushadhi Kendras' which are retail outlets selling these medicines.
- •PMBJP directly contributes to enhancing healthcare affordability and accessibility by creating a robust distribution network for generics, thereby reducing out-of-pocket expenditure on medicines for millions.
Exam Tip
Remember the launch/revamp years (2008/2015) and the key mechanism (JanAushadhi Kendras). UPSC might ask about the scheme's objectives or its operational model.
6. What are the main arguments for and against mandating doctors to prescribe drugs by their generic names, especially for a "critically examine" type question in Mains?
Mandating generic prescriptions has both strong arguments for and against it.
- •Arguments For: Enhances affordability by promoting cheaper alternatives, reduces influence of pharmaceutical marketing on prescribing practices, increases patient access to essential medicines, and fosters competition in the drug market.
- •Arguments Against: Concerns about doctor's autonomy and clinical judgment, potential for pharmacists to dispense lower-quality generics if quality control is not stringent, patient trust issues if they perceive generics as inferior, and potential for reduced innovation if branded drug companies face significant market erosion.
Practice Questions (MCQs)
1. Consider the following statements regarding generic medicines in India: 1. Generic medicines are required to have the same active pharmaceutical ingredients as their branded counterparts. 2. The Government of India's recent push mandates that generic drugs should only be dispensed based on a doctor's prescription. 3. The Drugs and Cosmetics Act, 1940, primarily regulates the pricing of generic medicines to ensure affordability. Which of the statements given above is/are correct?
- A.1 only
- B.2 only
- C.1 and 2 only
- D.1, 2 and 3
Show Answer
Answer: C
Statement 1 is CORRECT: Generic medicines are defined as drugs that are identical or bioequivalent to a brand-name drug in dosage form, safety, strength, route of administration, quality, performance characteristics, and intended use. This means they must contain the same active pharmaceutical ingredients (APIs) as their branded counterparts. Statement 2 is CORRECT: The recent government initiative explicitly reiterates that generic drugs should only be dispensed based on a doctor's prescription. This aims to address concerns about quality and efficacy and ensure medically guided use. Statement 3 is INCORRECT: The Drugs and Cosmetics Act, 1940, and its rules primarily regulate the manufacture, sale, and distribution of drugs in India, focusing on quality, purity, and standards. While affordability is a goal of promoting generics, the pricing of essential medicines is primarily regulated by the National Pharmaceutical Pricing Authority (NPPA) under the Drug Price Control Orders (DPCOs), not directly by the Drugs and Cosmetics Act.
2. Which of the following statements best describes the primary objective of the Government of India's intensified efforts to promote generic medicines? A) To increase the revenue of domestic pharmaceutical companies by encouraging local production. B) To ensure that all medicines, regardless of type, are sold at a uniform, government-controlled price. C) To enhance healthcare affordability and accessibility for citizens by reducing medicine costs. D) To replace all branded medicines with generic alternatives in the Indian market.
- A.To increase the revenue of domestic pharmaceutical companies by encouraging local production.
- B.To ensure that all medicines, regardless of type, are sold at a uniform, government-controlled price.
- C.To enhance healthcare affordability and accessibility for citizens by reducing medicine costs.
- D.To replace all branded medicines with generic alternatives in the Indian market.
Show Answer
Answer: C
Option C is the correct answer. The original summary explicitly states that the government's efforts are aimed "to enhance affordability and accessibility of healthcare" and "to reduce healthcare costs for citizens." This directly aligns with the goal of making essential medicines more affordable and accessible. While increasing domestic production (Option A) might be a secondary benefit, it's not the primary stated objective. Option B is incorrect as the government does not aim for uniform pricing for all medicines, but rather to promote cheaper alternatives. Option D is an overstatement; the goal is to promote generics, not to entirely replace all branded medicines.
Source Articles
NMC puts on hold rules for doctors to prescribe only generic medicines | India News - The Indian Express
What is data exclusivity, and how government push may hit availability of cheap, generic drugs | Explained News - The Indian Express
Compulsion to prescribe generic medicines an ill-thought move, say doctors, demand deferment of NMC regulation | Pune News - The Indian Express
India’s generic drug juggernaut was unstoppable amid US tariffs. Why a new trade deal may not change that | Health and Wellness News - The Indian Express
Why doctors are protesting rule to prescribe generic drugs | Explained News - The Indian Express
About the Author
Ritu SinghPublic Health & Social Affairs Researcher
Ritu Singh writes about Social Issues at GKSolver, breaking down complex developments into clear, exam-relevant analysis.
View all articles →